These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24996770)

  • 21. Complement in clinical medicine: Clinical trials, case reports and therapy monitoring.
    Ricklin D; Barratt-Due A; Mollnes TE
    Mol Immunol; 2017 Sep; 89():10-21. PubMed ID: 28576323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.
    Nester CM; Brophy PD
    Curr Opin Pediatr; 2013 Apr; 25(2):225-31. PubMed ID: 23486421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics.
    Melis JP; Strumane K; Ruuls SR; Beurskens FJ; Schuurman J; Parren PW
    Mol Immunol; 2015 Oct; 67(2 Pt A):117-30. PubMed ID: 25697848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renaissance of complement therapeutics.
    Ricklin D; Mastellos DC; Reis ES; Lambris JD
    Nat Rev Nephrol; 2018 Jan; 14(1):26-47. PubMed ID: 29199277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of rejection: role of complement.
    Farrar CA; Sacks SH
    Curr Opin Organ Transplant; 2014 Feb; 19(1):8-13. PubMed ID: 24316762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation.
    Biglarnia AR; Nilsson B; Nilsson T; von Zur-Mühlen B; Wagner M; Berne C; Wanders A; Magnusson A; Tufveson G
    Transpl Int; 2011 Aug; 24(8):e61-6. PubMed ID: 21696455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement in glomerular disease.
    Vernon KA; Cook HT
    Adv Chronic Kidney Dis; 2012 Mar; 19(2):84-92. PubMed ID: 22449345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Complement in organ xenotransplantation].
    Dalmasso AP
    Rev Clin Esp; 1996 Mar; 196 Spec No():44-51. PubMed ID: 9206808
    [No Abstract]   [Full Text] [Related]  

  • 29. Many drugs for many targets: novel treatments for complement-mediated glomerular disease.
    Thurman JM
    Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i57-i64. PubMed ID: 28391332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs that inhibit complement.
    Schrezenmeier H; Höchsmann B
    Transfus Apher Sci; 2012 Feb; 46(1):87-92. PubMed ID: 22169380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
    Dragun D
    Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Complement in Organ Transplantation.
    Grafals M; Thurman JM
    Front Immunol; 2019; 10():2380. PubMed ID: 31636644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-complement therapy for glomerular diseases.
    Bomback AS
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):152-8. PubMed ID: 24602464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of complement in innate immunity and host defense.
    Trouw LA; Daha MR
    Immunol Lett; 2011 Jul; 138(1):35-7. PubMed ID: 21333684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation.
    Spirig R; Gajanayake T; Korsgren O; Nilsson B; Rieben R
    Mol Immunol; 2008 Oct; 45(16):4084-94. PubMed ID: 18722664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complement system in systemic autoimmune disease.
    Chen M; Daha MR; Kallenberg CG
    J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Approaches to Block Complement.
    Böhmig GA; Wahrmann M; Eskandary F; Rostaing L
    Transplantation; 2018 Nov; 102(11):1837-1843. PubMed ID: 29870459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic complement inhibition: new developments.
    Emlen W; Li W; Kirschfink M
    Semin Thromb Hemost; 2010 Sep; 36(6):660-8. PubMed ID: 20865643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement activation and cardiovascular disease.
    Bjerre M; Hansen TK; Flyvbjerg A
    Horm Metab Res; 2008 Sep; 40(9):626-34. PubMed ID: 18792874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.